EC4 Strategic
Plan 2005-2008
Table of Contents
- Introduction
- Strategy
- Goals of EC4
- Structure of EC4
- Profession regulation (CARE for the profession)
- Performance of the profession
- Performance of laboratories (CARE for the laboratories)
- Performance of laboratories (CARE for laboratory data)
- Profiling towards European bodies and organisations
- Promotion of EC4 activities
- Strategic Actions related to the Strategic
Plan 2002-2005
1. Introduction The
freedom of movement of people and goods within the European Union
(EU) has a large impact for the member states. Particularly within
health care it is important to demonstrate, or if necessary ensure,
an adequate level of the quality of profession and practice, so that
citizens know that health care is offered in their country at a level
comparable to other countries.
The importance of recognition also
applies to laboratory medicine. This was envisaged by the National
Societies of Clinical Chemistry in EU countries related to the
International Federation of Clinical Chemistry and Laboratory Medicine
(IFCC).
The common political reality led to the institution of the European
Communities Confederation of Clinical Chemistry (EC4) on 27th
of April 1993. On September 14th 2002, the name was changed in conformity
with that of IFCC and the Federation of European Societies of
Clinical
Chemistry and Laboratory Medicine (FESCC) to the European Communities
Confederation of Clinical Chemistry and Laboratory Medicine (EC4).
EC4
is the organization of societies for clinical chemistry and laboratory
medicine in the EU and the Executive Board
consists
of representatives
from the societies. The EC4 member societies are members of
the IFCC as well of its broad European regional branch (FESCC).
To
indicate its plans for the near future and to open them for discussion,
the
board of EC4 publishes its Strategic Plan 2005-2008. It succeeds
the Strategic Plans 2002-2005 and 1999-2002 of which all
of the
planned actions were fulfilled. The new Plan builds on the
work of
the previous
Strategic Plans and is more focussed on actions designed
to produce direct benefit for the patient.
Table
of Contents
2. Strategy In
European health care, patients are treated in a health care “chain”.
In this chain, patients move quickly from primary health institutes
to secondary and tertiary institutes, and vice versa. This situation
involves many health care workers and may include several different
laboratories. Diagnosis and therapy are now central to health care
and medical laboratories play an essential role in this.
The broad
spectrum of medical laboratory investigations makes the consultant
role of the medical laboratory specialist ever more important.
The quality of both professionals and laboratories, as well as continuity
of laboratory data within and between laboratories is of the utmost
importance.
EC4 is active in giving support to attain such
quality and to ensure that laboratory medicine is practised at an adequate
level throughout
Europe.
In most countries this is already the case and
EC4 plays a central role in co-ordinating mutual recognition on the
basis of
existing
equivalence of standards. The Co-ordination of Automatic Recognition
of Equivalence
of standards (CARE) is important at three levels, CARE for the
profession, CARE for quality of laboratories and CARE for laboratory
data. Together,
these result in proper standards of patient care.
Table
of Contents
3.
Goals of EC4 The goals of EC4 include
co-operation and harmonisation in the field of laboratory medicine.
The efforts are focussed on several aspects:
- Co-operation for the advancement of clinical
chemistry and laboratory medicine as a science, in its fundamental
aspects as well as in its application, within the European Union
in particular and Europe in general.
- Co-operation to reach recognition
of professional qualifications of the profession on a European
level, in compliance with the principles
of free movement of professionals within the EU.
- Co-operation and
recognition of equivalence of standards in the field of training
of specialists in clinical chemistry and laboratory
medicine, irrespective of their varying academic background.
- Co-operation
and recognition of equivalence of standards of accreditation and
quality systems of medical laboratories
- Co-operation to introduce
a common professional view in ISO and CEN deliberations
- Co-operation
in defining guidelines on a European level for the performance
of the profession and the laboratory management
of
disease.
- Co-operation in evaluating effects of EU directives
on professional matters
- Co-operation in evaluating effects of EU
directives related to laboratories and laboratory data
- Communicating
with and informing the public on the significance of their laboratory
data
In the 2005-2008 Strategic Plan the following five main
issues are elaborated to reach the goals:
- Profession Regulation
- Performance of the
profession
- Performance of laboratories
- Liaison with European and other
bodies
- Promotion of EC4 activities
Table of Contents
4. Structure of EC4 The
structure of EC4 is depicted by the following diagram:

The
Executive Board is formed by the President of EC4, the Secretary,
the Treasurer and two
Members at Large. The officers are all elected by the General
Assembly. In 2005 new officers will be elected. The President
ends his second term and is not re-electable.
At
meetings of the Executive Board the chairmen of the working groups
are normally invited to report. The main responsibility
of the Executive Board in the Strategic Plan period will be
the co-ordination of the work in an enlarged European
Union. On May
1st 2004 ten countries joined the European Union bringing the
total number to 25 member states. In 2007 further expansion
is planned.
The EC4 Register plays a central role in many of the EC4
activities. The increasing number of applicants to the Register
requires
a more professional organisation. A legal body (Foundation) for
EC4 was established in September 2002.
A bank account was opened
and internet banking is currently in use. The Treasurer of
the Executive Board should set up a debiting and accounting system
and should see to external control of the EC4 accounts.
The
web
site is under the responsibility of the Web master. Both
web site and Register database have been completely revised.
The
RC secretary manages the daily operation of the Register.
The secretary of the Executive Board manages the secretariat
of
EC4. The Web master manages the maintenance of the web site.
The Registration
Commission deals with all matters concerning the maintenance
of the Register. The Registration Commission
is composed of representatives from the National Clinical Chemistry
and Laboratory Medicine Registration Committees. The chair
is elected at the General Assembly. In 2005 the chair ends
her first
term and is re-electable.
The working group
Profession deals with the promotion of the Register and the
contacts with the
European Commission. It also
monitors EU directives and draft directives on issues important
for profession or laboratories.
The working group ISO CEN co-ordinates the efforts to influence
ISO and CEN with respect to issues pertaining to laboratory
medicine.
The working group
on Accreditation co-ordinates the efforts for harmonisation
of accreditation and quality systems.
It
defines
Essential Criteria to achieve such harmonisation.
The working
group on Competence to be a Consultant defines guidelines
for duties and competences of consultant clinical
biochemists.
The working group
on Number of Consultant Clinical Biochemists defines Essential
Criteria for the appropriate
number
of professionals in various categories of medical laboratories.
The
working group on Guidelines for Investigation of Disease
issues European Guidelines for laboratory investigation
of disease in specific fields of laboratory medicine
based
on
peer reviewed
evidence.The working group
functions as a steering group, initiating project groups of
multi-disciplinary
membership
on various topics.
The working group
Vision defines the important areas where our profession and
EC4 should focus
on in the
future.
The project group
EQUAL has initiated a project on quality assessment in DNA-analysis
in routine
clinical
chemistry
laboratories.
The working groups
will be encouraged to proceed with their work. Young colleagues
should be
interested to
participate.
Table
of Contents
5. Profession Regulation (CARE for the profession) EC4
Register
Background
The installation of the EC4 Register
of European Specialists in Clinical Chemistry and Laboratory Medicine
is a major step forward to the attainment
of the first level, Recognition of Equivalence of Standards of the
profession.
Individual medical laboratory specialists should
and do apply for registration. In most EU countries National Registers
of
medical laboratory specialists exist. In some countries several registers
exist, depending on the academic background of the medical laboratory
specialist.
Such National Registers may apply for EC4RC Recognition
of Equivalence of Standards. In some EU countries no national register
exist and EC4 encourages and helps these countries to set up such a
Register. Colleagues from all relevant academic background, scientific
as well as medicine, pharmacy, veterinary, and other, if registered
in their National Register can and do apply for registration in the
EC4 register.
The name ‘Clinical Chemist’ causes
confusion and inhibits some colleagues from applying. Therefore the
name was
changed into European Specialist in Clinical Chemistry and Laboratory
Medicine in 2002, keeping, however, the existing abbreviation EurClinChem.
Operation
To set up the register, EC4 installed
a register commission (EC4RC) in 1997. The Register was opened in
1998. Each society was invited
to send one delegate from the National Clinical Chemistry Registration
Commission (NCCRC) to EC4RC. A board was elected and the structures
for the operation of the register were developed. The operation
of the register is based on the European Syllabus (defining the necessary
items of postgraduate education), the Guide to the Register (giving
the basic education and the rules for entering the register), and
the Code of Conduct (defining the criteria of behaviour of professionals
in our discipline).
The EC4 Register is based on the Recognition
of Equivalence of Standards to national registers by the EC4 Registration
Committee
and the EC4
Board. A major task for the EC4RC will be the co-operation with
and inclusion of the new countries.
During the Strategic Plan
period the recognition of equivalence of standards of the national
registers
should
be renewed for all countries, both old and new EU member states.
The criteria which are used for recognition should be revised.
Terms
of
reference should be defined as well as the final attainment
level. The way training sites are inspected should be part of the criteria
for recognition. Checklists for assessors and procedures for
assessment or inspection should be defined. Criteria for training
of
assessors
should be made.
National Register committees are keeping the
national registers and are asked to keep EC4RC well informed about
the national
education and training structure. If more than one national
register exists,
e.g. for different academic backgrounds, EC4RC expects a
joint representative
from that country. Following the guide to the register, EC4RC
acknowledges those national registers that meet the requirements
of the Syllabus
and other criteria.
Individual applications have to be voted
by both NCCRC and EC4RC.
If there is no national post graduate
education
and no national register organised, EC4RC encourages
and assists the national
society to set up such register. Applications from such
member state
are considered on an individual basis.
A third revision of
the Syllabus will be prepared.
The minimum number of years of training
and experience was recently extended from eight years to nine, i.e.
four or
five years academic
plus four or five years postgraduate specialist training,
in total nine years.
A new Code of Conduct was published
in 2004. Consent to the Code should be part of the criteria used
by the
national
registers and by the EC4RC.
The Code will play an important role in new EU directives
relating to the common values of regulated
professions,
like
the proposed directive on Recognition of Professional
Qualifications and the proposed directive on Services.
The
EC4RC should contribute actively in co-operation with the working
group on Profession to achieve that
the EC4
Register becomes a
Common Platform within the framework of the EU Directive
on
Recognition of Professional Qualifications.
Re-registration
Re-registration is becoming an
issue in many countries. Initial registration as European Specialist
in
Clinical Chemistry
and Laboratory Medicine
is granted for five years. The first applicants
should re-register starting from 2005. The system for re-registration
should
be further developed, starting by using existing
national systems.
Continuous
professional development will be part of the
criteria for re-registration. Further guidelines for terms
for such
systems will be issued.
Common Platform
The free exchange of goods and services and
the freedom of movement within the European Union
include the
free exchange
of professionals
between all member states. To make sure that
the competence of all specialists in clinical
chemistry
and laboratory
medicine fulfils a common minimum standard
EC4 agreed to promote recognition
of
the
profession
by establishing a European register. The main
goal is to achieve recognition of the EC4 Register
as
a so-called
Common Platform
by the European
Commission and the EU Member States within
the framework of the
EU Draft Directive on Recognition of Professional
Qualifications.
EC4
is active to convince the Commission of the
necessity to
recognise a system of Common Platforms governed
by the professions under
the supervision of a General European Board
of National Co-ordinators. The EC4 Register should
become such
a Common Platform. The
European Parliament and the European Commission
have voted in favour on
the
draft directive in second reading. National
politicians should now be motivated to vote in favour. The
position of specialists
in clinical
chemistry and laboratory medicine and how
clinical chemistry and laboratory medicine is organized
in Europe should
be explained as well as the
necessity of a Common Platform.
The co-operation
with CEPLIS and
the European Economic and Social Committee
to achieve a Common Platform will be extended.
Register -status and web site
The EC4 Register plays a central
role in many of the EC4 activities. An increased number
of European
Specialists
in Clinical Chemistry
and Laboratory Medicine will facilitate
the work. Therefore the number of registered
colleagues should be increased.
A system
should be
considered
of opting out from automatic registration
in the EC4 register
once a person is (re-) registered in
national register that has equivalence
of standards. Facilities should be added
to the
web site for individuals to review their
personal record
and notify
the
RC secretariat of
any changes needed. The database of registered
professionals should be
accessible to the public. Facilities
should be added for re-registration. Also a database
should
be installed
detailing
the recognition
of equivalence of standards of national
registers.
Table
of Contents
6. Performance of the profession
Competence
to be a Consultant
A working group was installed to define guidelines
concerning duties and competences of heads of clinical chemistry laboratories
and senior
consultants. In addition Essential Criteria concerning interpretation
skills, contacts with clinicians and the effective and efficient use
of laboratory tests and service in quantity and quality will be defined
as well as competences in relation to academic background.
Patient information
There is a definite
need for information among patients and the public in general. Sites
like Lab Tests Online (UK and The Netherlands)
are gaining increasing interest. Developments like the patient
questions
platform in the Netherlands are frequently used media. A working
group should be installed to provide guidelines and help for national
organisations
to set up web sites in the native language like Lab Tests Online
and Information and questions for the public.
Table
of Contents
7. Performance of laboratories (CARE for laboratories)
ISO/CEN
EC4 co-ordinates and promotes the
voice of professionals in the relevant CEN and ISO committees and working
groups to improve the influence
of the profession on the development of standards, that influence
directly our work. The chair of the WG presently is chair of ISO
TC212 WG 1 and EC4 is happy to support him.
Focus will be on the
revision of ISO 15189. Several EC4 publications have contributed
to the development of the ISO 15189 International Standard, which
defines requirements for quality and competence of medical laboratories.
Now that this is a published standard, the WG will co-ordinate
the input for the next version of it.
Attention will be given also
to
documents under development, in particular regarding POCT and
Safety. The working group should also contribute in the monitoring
of the
implementation of the EU IVD directive.
Different interpretations
in individual countries of the IVD Directive ruling on in house
testing, threatens expert centres and new or commercially not interesting
tests. The working group should monitor new developments in
ISO and
CEN which influence medical laboratories and should inform
national societies on these developments.
Quality systems and Accreditation
EC4 co-ordinates
activities towards the European co-operation for Accreditation (EA)
and national accrediting organisations,
with
regard to mutual
recognition of accreditation systems for medical laboratories.
Several colleagues in the working group on Accreditation
have a seat on the
EA committee on Laboratory Medicine, including the representative
from EC4/FESCC. The input from the profession in the committee
will be co-ordinated
in the WG. The focus of the WG will be on the use of ISO 15189
as the standard for accreditation.
The EC4 Essential Criteria are widely used
as practical guidelines for implementation of quality systems in
medical laboratories. The
EC4 Model Quality Manual is a further tool to help individual laboratories
to set up their quality system. It should, however, be issued in a
much more condensed form, reducing the size and turning it into a content
list document.
Criteria for inspections of medical laboratories
as well as for assessors will be defined. Advice will be given on
the co-ordination
of exchange
of accreditation inspectors between EU countries. Additional Essential
Criteria should be defined regarding continuous quality improvement,
systems for document control, retention time of specimens, archiving
of documents, retention time of records. Guidelines on method validation
should be issued, and guidelines on expressing uncertainty of measurements.
The specific nature of the medical laboratory requires essential
criteria for clinical audit in laboratory medicine. Also criteria
for internal
audit including audit checklists are needed.
Table
of Contents
8. Performance of laboratories (CARE for laboratory data)
Guidelines
for Investigation of Disease
One of the main responsibilities of
our profession is to give advice on the use and interpretation of laboratory
data. There exist many
books and publications regarding this subject. In a unifying Europe
it is important to have (European) Guidelines on the Laboratory Investigation
of Disease.
The working group GID functions as a steering group.
It initiates multidisciplinary project groups on specific topics including
experts from the laboratory discipline as well as from the clinical
side. The guidelines should be evidence based. Co-operation should
be sought with existing organisations like the Guidelines International
Network (GIN).
EC4 will be active in this field in co-operation
with FESCC and other European organisations in laboratory medicine,
and
in particular also other European medical specialists’ organisations,
to publish such guidelines. Guidelines were published on inherited
thrombophilia. The project group on IVD effect on creatinine result
interpretation was started in 2004. It will publish guidelines in the
Strategic Plan period. Project groups on guidelines for cardiac disease,
thyroid disease and other will be started in the Plan period.
A guideline
database including primarily laboratory, or lab-related guidelines
would be extremely useful. There are many guidelines, but
it is quite often difficult to find special recommendations within
guidelines on the use of lab tests. Such an information resource
should be developed.
A main additional issue will be the development
of model diagnosis related request forms, which will be developed
for requesting specialists
as well as general practitioners.
EQUAL
In 2004 the first meeting of
the EQUAL project took place. The EQUAL project was initiated by
EC4 and aims at the development of a European
quality assessment scheme and training courses in DNA analysis
in clinical chemistry laboratories. The project obtained a large
grant
from the European Commission. The project should be running in
2005 and results should be published in 2006-2007.
EC4 should consider
establishment of a comparable project in the field
of proteomics.
Desirable Analytical Performance The
joint FESCC/EC4/EDMA working group on desirable analytical performance
should define Essential Criteria concerning clinically
relevant analytical
requirements, based on published work and in relation to the
EU IVD directive. Another important field is unified acceptance
limits
for
EQAS, based on the above. In a joint EU, it is important to harmonise
these limits.
Calibration of data
EC4 stimulates
developments for harmonisation of laboratory data. The Calibration
2000 project of The Netherlands is such a
project. The
materials developed in this project are commutable with patient
materials and should be tested on an international base to
investigate their
potency as Trueness Verification Materials.
The EU IVD directive
requires traceability to reference systems. Verification
of such traceability
requires commutable materials and international co-operation
between NEQAS organizers and national societies. It is
the responsibility of the medical laboratory specialist to estimate
within and between
laboratory
variations and to decide whether correction for observed
bias is
needed in a particular laboratory situation. This could
be
done in co-operation
with the industry. For such corrections commutable trueness
verification materials are necessary. EC4 will continue
to stimulate projects
in this field.
Table
of Contents
9. Profiling towards European bodies and organisations
Co-operation
with other European organisations
FESCC
In order to improve the image and functioning
of laboratory medicine in Europe, co-operation between the various
European umbrella organisations
is important. The EC4 Executive Board will put effort in maintaining
and extending such co-operation.
EC4 is an autonomous working group
within FESCC. All of the EC4 work and documents are sent to and
available for FESCC. The boards of FESCC and EC4 maintain a close working
relationship.
The future relationship of FESCC and EC4 should be considered in
the light of the recent enlargement and future enlargement of the
European Union. As more European countries join the EU, the two organisations
should work towards becoming a single organization. However, the
active
nature and the productivity of EC4 should be conserved in that
organization.
Other professional umbrella organisations
EC4 strives
for co-operation with other European umbrella organisations in laboratory
medicine,
such as UEMS section Bio-pathology.
EC4 should re-consider its position
regarding a European Platform of Laboratory Medicine and the co-operation
with other umbrella
organisations in laboratory medicine.
Professional involvement
in the different EU bodies which deal with aspects of clinical chemistry
and laboratory medicine
is essential. The importance of clinical chemistry and laboratory
medicine, in
its broad definition as defined in the Guide to the European
Register, and all activities performed in EC4 must be more
widely
known in
the
EU official bodies.
EC4 will seek contact with the European
Commission to clarify the importance of clinical chemistry
and laboratory
medicine
in all its aspects for the improvement of patient care
in the EU. Therefore it is essential to maintain a list of all EU-bodies
relevant
to and
dealing with the medical laboratory profession. This will
facilitate
the recognition of the European Register and EC4 views
on
accreditation. The extension of the EU is an exciting challenge for
EC4. EC4
will see to a firm integration of the new countries in
the EC4 work.
European Commission
The monitoring of EU draft directives
and their consequences for the medical laboratory professionals and
medical
laboratories is
an important
task for EC4. EC4 will co-ordinate activities and communicate
developments to the national societies. Regulations
of direct importance at
present are the draft directive on recognition of professional
qualifications,
the draft directive on services in the internal market,
the directive providing an information procedure in
the field
of technical
standards and regulations, the EU Questionnaire on
the common values of the
regulated professions in Europe, and the IVD directive.
ISO,
CEN and EA
EC4 realises that it is difficult for national
societies to keep up to date with the various international
standards, draft
standards
and
documents of ISO, CEN and other bodies. The notifying
of member societies of current developments in
CEN and ISO
will be structured.
The WG
will produce simple guidance documents to assist
national societies in understanding
and applying ISO/CEN documents. EC4 continues to
encourage the national societies to find their way to the National
Accreditation Bodies
and Standardisation Institutes. Within the working
group on ISO/CEN
a network
has been established to share experience and co-ordinate
influence on CEN and ISO working groups and on
EU directives.
With regard
to accreditation EC4 will continue to influencing
the European c-operation
on Accreditation (EA).
EDMA
Co-operation with the industry is important
in scientific matters, EU regulations and directives,
accreditation,
and quality requirements
and assessment. EC4 should be in close contact
with EDMA.
Web site
The communication of EC4 activities towards
member societies, European Commission,
the medical profession
in Europe,
the public in Europe,
industry and relevant European organisations
is extremely important and will be extended.
The EC4
website will
play an important
role in the providing of information. The
maintenance of the website
will be
professionalized.
10. Promotion of EC4 activities
EC4
maintains a web site on the Internet. The web site will contain all
available information about EC4. Links are available to sites of
IFCC, FESCC, national societies and other organisations relevant
to EC4.
To promote the Register an EC4 Newsletter will
be published regularly on the web site and if relevant in Clinical
Chemistry and
Laboratory
Medicine (CCLM). Information will be given on numbers of registrants,
political status of the Register, receipt status of the Register
in EU member states, EC4RC meetings, and progress of the working
groups.
National societies will be encouraged to report
on EC4 in their national journals and material will be sent to facilitate
this.
National societies
will be asked to distribute information on the European register
and to stress the importance of it.
There will be continuing publicity
on EC4 in CCLM. The board will co-ordinate the timing of the various
publications.
A central record of existing EC4 papers and translations of these
will be available.
Table
of Contents
11. Strategic
Actions related to the Strategic Plan 2005-2008
| Action |
Plan |
| |
|
| Strategic actions for the EC4 executive board |
| |
|
| Organisation |
|
| Election of new executive board officers in 2005 and 2008 |
2005/8 |
| Encourage participation of young colleagues in the working
groups |
cont |
|
|
| Communication |
|
Structured communication with member societies
|
cont
|
| Intensify contacts with and integration of the new EU countries |
2005 |
Co-ordinate activities in relation to EC towards the national
societies
|
cont |
Communicate developments regarding EU directives to societies
|
cont |
| Intensify contacts with candidate EU countries |
2006 |
Communication of EC4 activities to all relevant parties
|
cont |
| Issue the Newsletter half yearly on web site and by e-mail
to register members and societies |
2005 |
| Encourage National societies to report on EC4 |
cont |
| Encourage National societies to promote the Register |
cont |
| |
|
| Contacts other organisations |
|
| Intensify contacts with FESCC |
2005 |
| In the light of EU enlargement work towards one organization
with FESCC keeping the active and productive nature of EC4 |
2006 |
| Intensify contacts with UEMS section Bio-pathology |
2006 |
| Intensify contacts with other European umbrella organisations
in Laboratory Medicine |
2006 |
| Reconsider position towards European platform in LM and ELM |
2005 |
| Intensify contacts with EDMA on EU regulations and directives,
accreditation, and quality requirements |
2005 |
| Establish contacts with IRMM, EUROMET and other relevant organisations |
2007 |
| Maintain a list of relevant EU organisations, EC departments
and contact persons |
2007 |
| |
|
| Information and patient focus |
|
| Provide up to date information on the web site |
cont |
| Install a working group on Patient information |
2005 |
| Inform European Commission and the public |
2006 |
| Monitor impact of EU directives |
cont |
| |
|
| Laboratory data |
|
| Stimulate the development of commutable trueness verification
materials |
2006 |
| Stress to IFCC and EDMA the responsibilities of the profession
next to industry |
2006 |
| |
|
| Finances |
|
| Set up of debiting and control system for EC4 bank accounts |
2005 |
| External audit of EC4 accounts |
2005 |
| |
|
Strategic actions for the Registration
Commission
|
| |
|
| Communication and contacts |
|
| Establish and intensify contacts with national politicians
and authorities (via NCCRC’s) |
cont |
| Stress to national authorities importance of Common Platform |
2005 |
| Explain to national authorities the position of our profession |
2005 |
| |
|
| Recognition of Equivalence of Standards (RES) |
|
| Renewal of recognition of equivalence of standards of national
registers |
2005 |
| Revision of the Criteria for RES |
2006 |
| Define terms of reference |
2006 |
| Define final attainment level using work of WG Competences |
2006 |
| Define criteria and procedures for inspection of training sites |
2007 |
| Define checklist for assessors |
2007 |
| Define criteria for training of assessors |
2007 |
| Include assessment of training sites as criterion for RES |
2006 |
| Define database for RES and registers that obtained RES |
2006 |
| Third Revision of the Syllabus |
2005 |
| |
|
| National registers |
|
| Encourage active participation from the Swedish Society |
2005 |
| Initiating and inclusion of Registers in the new countries |
2006 |
| |
|
| Re-registration |
|
| Commence re-registration according to an agreed process |
2005 |
| Include signing of Code of Conduct in registration and re-registration |
2005 |
| Include participation in CPD as a criterion for re-registration |
2006 |
| Agree guidelines for systems of continuous professional development |
2007 |
| Define web site facilities needed for re-registration |
2005 |
| |
|
| Publicity |
|
| Improve publicity and promotion for the Register |
2005 |
List of registered professionals visible for public on web
site
Personal data review and notifying of needed changes possible on
web site taking into consideration data protection legislation
|
2006 |
| Increase number of registered colleagues to 4.000 |
2008 |
| Consider system of opting out for automatic (re-)registration
in EC4 Register |
2005 |
| Provide information on the web site on number of registrants,
political status of the Register, status of the Register in
EU member states, EC4RC meetings |
2006 |
| Consider subspecialties/other specialties on Register – mention
of competence in other areas |
2006 |
| |
|
Strategic action for the WG Profession |
| |
|
| Intensify contacts with the European Commission |
2006 |
| Establish contacts with European Parliament members |
2007 |
| Intensify contacts with CEPLIS and EESC |
2006 |
| Establish the Register as Common Platform in the EU |
2007 |
| Update the credentials map for the Common Platform |
2006 |
| Monitor proposed directive on Services |
2005 |
| Monitor directive on providing an information procedure in
the field of technical standards and regulations |
2005 |
| Introduce Code of conduct in EU regulations on common values
of regulated professions |
2005 |
| Intensify contacts with EDMA |
2005 |
| Intensify contacts with Laboratory Medicine organisations |
2006 |
| Provide information on the web site |
cont |
| |
|
Strategic
actions of the WG on Competence to be a Consultant |
| |
|
| Define guidelines concerning competence of heads of clinical
chemistry laboratories and senior consultants. |
2005 |
| Define competences in relation to academic background |
2006 |
| Define Essential Criteria concerning interpretation skills,
contacts with clinicians and the effective and efficient use of laboratory
tests and service in quantity and quality. |
2007 |
| |
|
Strategic
actions of the WG on ISO/CEN
|
| |
|
| Co-ordinate input for next version of ISO 15189 |
cont |
| Co-ordinate actions for documents on safety and POCT |
cont |
| Co-ordinate influence from the profession on new ISO and CEN
documents |
cont |
| Structure the notifying of member societies on ISO and CEN developments
via Newsletter |
2006 |
| Co-ordinate actions for use of ISO 15189 as stand alone accreditation
document toward EA |
2005 |
| Assist in the monitoring of the implementation of IVD directive |
2005 |
| Provide information on the web site |
cont |
| Produce introductory document to ISO/CEN docs – how to
understand them |
2005 |
| Monitor impact of EU directives |
cont |
| |
|
Strategic
actions of the WG on Accreditation
|
| |
|
| Define criteria for assessment of medical laboratories |
2006 |
| Define criteria for assessors of medical laboratories |
2006 |
| Issue statement with FESCC to IFCC and societies about accreditation
and necessity of the use of ISO 15189 |
2005 |
| Define Essential Criteria for continuous improvement and the
use of systems like quality indicators |
2008 |
| Produce a questionnaire on retention of documents |
2006 |
| Issue Model Quality Manual in condensed form as content list
document |
2006 |
| Issue guidelines for retention time of specimens |
2007 |
| Define guidelines on method validation |
2007 |
| Define guideline on expressing uncertainty of measurements |
2007 |
| Define essential criteria for clinical audit in lab. med. |
2008 |
| Define criteria for internal audit incl. audit checklists |
2008 |
| Advise on the exchange of inspectors between countries |
2008 |
| Communication of Essential Criteria under way |
2005 |
| Co-ordinate input in EA committee |
2005 |
| Provide information on the web site |
cont |
| |
|
Strategic
actions of the WG Guidelines for Investigation of Disease
|
| |
|
| Co-ordinate a system to set up several evidence based guidelines |
2005 |
| Publish guidelines from the project group on IVD effects on
creatinine result interpretation |
2006 |
| Establish links with GIN, IFCC C-EBLM STAG WG and other guideline
development groups |
2006 |
| Install project groups on guidelines for the topics Diabetes
management, Celiac disease, Cardiac disease management, Monoclonal
gammopathy, Thyroid disease in co-operation with other international
agencies |
2006 |
| Set up a guideline database |
2007 |
| Deliver a diagnosis oriented request form |
2008 |
| Provide information on the web site |
cont |
| |
|
Strategic
actions of the WG EQUAL
|
| |
|
| Ensure a sufficient number of participating laboratories |
2005 |
| Perform the trials |
2005 |
| Report to EC |
2006 |
| Publish results |
2007 |
| Initiate similar project on proteomics |
2006 |
| Hold discussions with QCMD on collaboration and grants |
2005 |
| |
|
Strategic actions
of the WG on Desirable Analytical Performance
|
|
|
| Define Essential Criteria concerning clinically relevant analytical
requirements, based on published work and in relation to the EU
IVD directive |
2006 |
| Define EQA limits based on the biological variation concept |
2006 |
| |
|
Strategic actions
of the Web master
|
| |
|
| Maintain the web site up to date |
cont |
| Make list of registered professionals public |
2005 |
| Make personal data accessible to registered people |
2005 |
| Make a system to let registered people have errors in their
data corrected |
2006 |
| Make a database for recognised national registers |
2006 |
| Prepare for data extraction towards a Common Platform database |
2007 |
| Ask chairs regularly to check and update their information
on the web site |
cont |
| |
|
Table
of Contents
|